IL6 and hepatocellular carcinoma: New findings suggest that IRE1α-XBP1 signaling promotes development of tumors such as hepatocellular carcinoma (HCC) or melanoma via upregulation of IL-6-driven Janus kinase-signal transducer and activator of transcription 3 (JAK-STAT3) signaling pathway.